Medicines Access Portal

The MAP is a single, secure online portal which allows clinicians to view Compassionate and Special Access Programs that pharmaceutical companies have available for cancer patients in Australia. 

The MAP lists treatment programs that are not publicly advertised in one, central location for ease of access for clinicians, allowing them to potentially provide more treatment options to their patients with complex, life-limiting cancer. 

Australian medical practitioners that have an AHPRA number can securely register to use the MAP website where they can search for information on available access programs. 

To comply with the Therapeutic Goods Act, the public are not able to access the MAP. However, treating clinicians will be able to talk to their patients and their carers about programs that could be relevant to them.  Cancer patients will benefit significantly from the MAP. For instance, Cancer specialists, especially those in regional, rural and remote areas, will have easier and faster access to information about medicines and treatments and will be able to offer more care options to their patients. 

Endorsed by the Therapeutic Goods Administration, the MAP has been developed by Rare Cancers Australia and Medicines Australia under the leadership of Professor John Zalcberg OAM and in collaboration with the Medical Oncology Group of Australia, the TGA, the Pharmaceutical Benefits Advisory Committee, industry representatives and clinicians. 

If you have any questions or for more information please contact map@rarecancers.org.au 

To access the MAP : www.medicinesap.com